Trials / Completed
CompletedNCT06044610
Utility of Transdermal Optical Imaging (TOI) as a Non-invasive Measure of Hydration Status: Phase 3a for Model Development
Utility of Transdermal Optical Imaging TOI) as a Non-invasive Measure of Hydration Status: Phase 3a for Model Development
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- PepsiCo Global R&D · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to analyze smart phone-based Transdermal Optical Imaging (TOI) features to develop a model that can discern hypohydration from euhydration status including 1) a small feasibility study for 24-hour data collection in the general population using passive dehydration or ad libitum fluid intake (GENPOP), 2) an exercise study in moderately active participants in both dehydrated and euhydrated states (EXERCISE). TOI data will be collected alongside standard reference measures of hydration status. This is an exploratory pilot proof of concept study with each subject serving as their own control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | GENPOP Passive dehydration (75% reduction in fluid intake | Over 24-hours |
| OTHER | GENPOP Ad lib fluid intake | Over 24 hours |
| OTHER | EXERCISE without fluid replacement | 90-min standard cycling exercise trial in heat chamber |
| OTHER | EXERCISE with fluid replacement | 90-min standard cycling exercise trial in heat chamber |
Timeline
- Start date
- 2023-05-08
- Primary completion
- 2023-11-15
- Completion
- 2023-11-15
- First posted
- 2023-09-21
- Last updated
- 2024-01-19
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06044610. Inclusion in this directory is not an endorsement.